Publications Office of the EU
Conclusion of non-exclusive discount agreements pursuant to § 130a(8) SGB V with the active ingredient Ramipril + Amlodipine + HCT - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates text translated automatically in your browsing language

Conclusion of non-exclusive discount agreements pursuant to § 130a(8) SGB V with the active ingredient Ramipril + Amlodipine + HCT Text automatically translated in your browsing language Automatically translated

Overview
  • Published
    23/05/2024
  • Today
    21/10/2025
  • Deadline
    10/11/2025
Status
Published
Type of contract
Supplies
Subject for Renewal
No
Buyer
GWQ ServicePlus AG
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: DEA11 Düsseldorf, Kreisfreie Stadt
Business sector (Main CPV)
33600000 Pharmaceutical products
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
Not available
Procedure details
Tender reference number
Not available
Description

Section 130a(8) of the SGB V enables health insurance funds (KK) and pharmaceutical companies to conclude framework rebate contracts for medicinal products to be supplied at the expense of the statutory KK. GWQ acts as a company for efficiency and quality at KK in accordance with § 130a(8) SGBV for its shareholder and customer cash registers. With regard to the relevant statutory provisions on the award of public contracts, a regular process of active substance-related, formal procurement procedures takes place according to the regulations of Part 4 of the GWB by GWQ ServicePlus AG. Until new drug discount contracts enter into force, GWQ would like to conclude drug rebate agreements with all interested pharmaceutical companies. The start of the contract is 1.7.2024. Text automatically translated in your browsing language Automatically translated

Submission Method
Not available
Tenders may be submitted
Electronic submission: eu.europa.publications.PublicProcurement.electronic.submission.not-allowed
sen-info
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
Not available
Place of performance
DE Deutschland
DEA11 Düsseldorf, Kreisfreie Stadt
CPV code

33600000 - Pharmaceutical products

Award method
Not available
Estimated value
Not available
Final contracted value
Not available
Award of contract
Not available
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.